Perrin-Terrin, Aurélie <br/><br/>
QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.  [electronic resource] 

 -  Fundamental & clinical pharmacology  Aug 2011 
 - 503-10 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1472-8206 
<br/><br/><label>Standard No.: </label>10.1111/j.1472-8206.2010.00871.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Death, Sudden--epidemiology<br/>Death, Sudden, Cardiac--epidemiology<br/>Female<br/>France--epidemiology<br/>Heart Diseases--chemically induced<br/>Humans<br/>Long QT Syndrome--chemically induced<br/>Male<br/>Methadone--administration & dosage<br/>Middle Aged<br/>Opioid-Related Disorders--drug therapy<br/>Pharmacovigilance<br/>Prevalence<br/>Risk Factors<br/>Smoking--adverse effects<br/>Substance-Related Disorders--epidemiology<br/>Torsades de Pointes--chemically induced<br/>Young Adult